ESMO Presentation, page-19

  1. RBx
    245 Posts.
    lightbulb Created with Sketch.  50
    Harvett,

    Once again you have (deliberately?) distorted the truth.

    You state that "
    Even a placebo with carboplatin added at AUC2 proceduced (sic) a median PFS of 20 weeks. And we are suppose to applaud for 12 weeks." ​
    What you failed to say was that carboplatin at AUC=2 in this case was administered WEEKLY.​


    This was equivalent to AUC=8 monthly, twice the dose used with NOX66. I'm sure you will respond with some irrelevant data that suits your purpose, but I do not care. ​


    The great pity is that your vendetta has no doubt turned some investors off Noxopharm and thus deprived them of a windfall gain. Well done.​
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.